Sign in
8-K

Current Report

Cocrystal Pharma, Inc. Filed Acc 0001521536-11-000361

New debt or obligation · Debt accelerated · Unregistered share sale

  • Item 2.03 Creation of a direct financial obligation
  • Item 2.04 Triggering events that accelerate or increase an obligation
  • Item 3.02 Unregistered sales of equity securities

From the SEC's structured data for this filing

Loading q1100220_8k-biozone.htm…